Ropinirole: Difference between revisions - Wikipedia

Article Images

Content deleted Content added

Revision as of 21:58, 2 June 2022 edit

Whywhenwhohow

(talk | contribs)

Autopatrolled, Extended confirmed users, Pending changes reviewers

47,383 edits

← Previous edit

Revision as of 15:02, 23 June 2022 edit undo

2a00:23c8:8e90:ae01:b517:3a33:9c37:e1f2

(talk)

Tags: Reverted Mobile edit Mobile web edit

Next edit →

Line 51:

}}

'''Ropinirole''', sold under the brand name '''Requip''' among others, is a medication used to treat [[Parkinson's disease]] (PD) and [[restless legs syndrome]] (RLS).<ref name=BNF76>{{cite book|title=British national formulary : BNF 76|date=2018|publisher=Pharmaceutical Press|isbn=9780857113382|pages=419–420|edition=76}}</ref> In PD the dose needs to be adjusted to the effect and treatment should not be suddenly stopped.<ref name=BNF76/> It is taken by mouth.<ref name=AHFS2019/> It is approved in the USUK and UKUS for inducing emesis (vomiting) in dogs who have ingested toxins or non-sharp foreign material.